{"id":"W4304692114","doi":"10.1016/s2468-1253(22)00303-x","title":"Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trial","year":2022,"lang":"en","type":"article","venue":"˜The œLancet. Gastroenterology & hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary","funders":"F. Hoffmann-La Roche; Roche","keywords":"Medicine; Placebo; Cohort; Internal medicine; Concomitant; Crohn's disease; Adverse effect; Placebo-controlled study; Surgery; Gastroenterology; Disease; Double blind; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001336014,0.001210585,0.002421112,0.0002473218,0.0003239163,0.001040276,0.000746034,0.002156272,0.005641954],"category_scores_gemma":[0.001340274,0.0004968477,0.001552686,0.0002697254,0.000747625,0.00101739,0.0003518585,0.00254721,0.0007394155],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000683936,"about_ca_system_score_gemma":0.0006103794,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001153261,"about_ca_topic_score_gemma":0.002342002,"domain_scores_codex":[0.9996076,0.000186711,0.00002557703,0.00006181356,0.00002898804,0.00008935437],"domain_scores_gemma":[0.9994599,0.0001746698,0.0001186397,0.00002968162,0.00003269605,0.0001844077],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.972153,0.001483558,0.0005272049,0.001015155,0.0008509318,0.00006477324,0.0000555901,0.0001809611,0.002181955,0.0001178906,0.00135657,0.02001237],"study_design_scores_gemma":[0.9699693,0.02601128,0.002370347,0.00005877586,0.0003820213,0.00005065926,0.00002232548,0.0001814174,0.0001519644,0.00007553868,0.0007141825,0.00001221806],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9645088,0.02624506,0.0005202797,0.001849119,0.001131289,0.001424573,0.001277345,0.0001507808,0.002892826],"genre_scores_gemma":[0.981424,0.007302663,0.001145804,0.00223416,0.0006468851,0.001694482,0.001285397,0.00002098391,0.004245667],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005641954,"threshold_uncertainty_score":0.01887429,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01422734792694747,"score_gpt":0.2597048531549768,"score_spread":0.2454775052280293,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}